Concentrix Corporation (CNXC)
Official siteTECHNOLOGY • INFORMATION TECHNOLOGY SERVICES • NASDAQ
Market Cap: $2.00B
Last updated: Nov 17, 2026 at 11:05 AM ET
Concentrix Corporation (CNXC) Financials: Revenue, Profit and Cash Flow
Concentrix reported revenue of $9.83B for the fiscal year ended Nov 30, 2025, up 2.2% from the year before. That year, net income was -$1.28B with a net margin of -13.0%, operating cash flow was $806.97M and free cash flow was $572.47M. The quarter ended Aug 31, 2026 had revenue of $2.45B and net income of -$988.11M.
Revenue and Margins
The operating margin was -9.3% in the fiscal year ended Nov 2025, the lowest of the 9 years shown. Over the 8 years to Nov 2025, revenue grew from $1.99B, a compound annual rate of 22.1%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Nov 2025 | $9.83B | +2.2% | 35.0% | -9.3% | -13.0% |
| Nov 2024 | $9.62B | +35.2% | 35.9% | 6.2% | 2.6% |
| Nov 2023 | $7.11B | +12.5% | 36.2% | 9.3% | 4.4% |
| Nov 2022 | $6.32B | +13.2% | 35.7% | 10.1% | 6.9% |
| Nov 2021 | $5.59B | +18.4% | 35.3% | 10.2% | 7.3% |
| Nov 2020 | $4.72B | +0.2% | 35.2% | 6.5% | 3.5% |
| Nov 2019 | $4.71B | +91.1% | 37.1% | 6.3% | 2.5% |
| Nov 2018 | $2.46B | +23.8% | 38.1% | 5.9% | 2.0% |
| Nov 2017 | $1.99B | N/A | 37.6% | 5.8% | 3.6% |
Income Statement
In the fiscal year ended Nov 2025, the company posted a net loss after a profit the year before. In the quarter ended Aug 2026, the company posted a net loss after a profit in the same quarter a year earlier.
Annual
| Line item | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.83B | $9.62B | $7.11B | $6.32B | $5.59B | $4.72B | $4.71B | $2.46B | $1.99B |
| Cost of revenue | $6.39B | $6.17B | $4.54B | $4.07B | $3.62B | $3.06B | $2.96B | $1.53B | $1.24B |
| Gross profit | $3.44B | $3.45B | $2.58B | $2.26B | $1.97B | $1.66B | $1.75B | $937.55M | $749.15M |
| Operating income | -$918.18M | $596.39M | $661.33M | $640.19M | $572.40M | $308.76M | $294.33M | $144.76M | $114.62M |
| Net income | -$1.28B | $251.22M | $313.84M | $435.64M | $405.58M | $164.81M | $117.16M | $48.27M | $72.25M |
| EBITDA | -$207.89M | $1.35B | $1.00B | $986.39M | $857.57M | $592.77M | $602.39M | $303.75M | $242.16M |
Quarterly
| Line item | Aug 2026 | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | Feb 2024 | Nov 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.45B | $2.46B | $2.50B | $2.55B | $2.48B | $2.42B | $2.37B | $2.45B | $2.39B | $2.38B | $2.40B | $2.23B |
| Gross profit | $848.88M | $823.35M | $849.66M | $875.96M | $855.01M | $848.15M | $855.90M | $870.60M | $864.19M | $857.57M | $856.53M | $822.86M |
| Operating income | -$910.30M | $95.42M | $118.56M | -$1.38B | $146.98M | $148.34M | $168.87M | $144.54M | $153.24M | $150.17M | $148.44M | $180.45M |
| Net income | -$988.11M | $55.28M | $21.59M | -$1.48B | $88.11M | $42.09M | $70.26M | $115.65M | $16.63M | $66.83M | $52.10M | $69.49M |
Balance Sheet
As of Nov 2025, total debt of $4.64B exceeded cash and equivalents by $4.31B.
Annual
| Line item | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | $10.76B | $11.99B | $12.49B | $6.67B | $5.05B | $5.18B | $4.65B | $4.77B | N/A |
| Current assets | $3.08B | $2.84B | $2.86B | $1.75B | $1.54B | $1.42B | $1.30B | $1.30B | N/A |
| Cash and equivalents | $327.35M | $240.57M | $295.34M | $145.38M | $182.04M | $152.66M | $83.51M | $123.39M | N/A |
| Total liabilities | $8.02B | $7.95B | $8.35B | $3.97B | $2.43B | $2.88B | $3.18B | $3.45B | N/A |
| Short-term debt | $65.63M | $2.52M | $2.31M | $0 | $0 | $33.75M | $2.07B | $2.24B | N/A |
| Long-term debt | $4.57B | $4.73B | $4.94B | $2.22B | $802.02M | $1.11B | N/A | N/A | N/A |
| Shareholder equity | $2.74B | $4.04B | $4.14B | $2.70B | $2.62B | $2.30B | $1.47B | $1.32B | N/A |
Quarterly
| Line item | Aug 2026 | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | Feb 2024 | Nov 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $9.26B | $10.51B | $10.67B | $10.76B | $12.41B | $12.40B | $11.90B | $11.99B | $12.21B | $12.08B | $12.24B | $12.49B |
| Total liabilities | $7.49B | $7.81B | $7.89B | $8.02B | $8.07B | $8.12B | $7.86B | $7.95B | $8.04B | $8.00B | $8.14B | $8.35B |
| Cash and equivalents | $244.69M | $255.57M | $222.70M | $327.35M | $350.26M | $342.76M | $308.00M | $429.60M | $246.24M | $207.34M | $234.79M | $516.49M |
| Shareholder equity | $1.77B | $2.70B | $2.79B | $2.74B | $4.34B | $4.28B | $4.03B | $4.04B | $4.17B | $4.08B | $4.10B | $4.14B |
Cash Flow
In the fiscal year ended Nov 2025, free cash flow was 70.9% of operating cash flow. Dividends and share repurchases together came to 45.1% of it.
Annual
| Line item | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 | Nov 2020 | Nov 2019 | Nov 2018 | Nov 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $806.97M | $667.49M | $678.01M | $600.72M | $514.18M | $507.61M | $449.74M | $212.32M | $168.37M |
| Capital expenditures | $234.50M | $238.76M | $180.53M | $140.02M | $149.08M | $171.33M | $111.12M | $92.52M | $78.70M |
| Free cash flow | $572.47M | $428.73M | $497.48M | $460.70M | $365.10M | $336.28M | $338.61M | $119.81M | $89.66M |
| Dividends paid | $89.62M | $83.81M | $63.49M | $53.43M | $13.08M | $0 | $13.08M | $13.08M | N/A |
| Share repurchases | $168.71M | $136.10M | $63.96M | $123.32M | $25.10M | $0 | N/A | N/A | N/A |
| Investing cash flow | -$250.38M | -$244.27M | -$2.11B | -$1.84B | -$78.65M | -$109.22M | -$151.01M | -$1.15B | -$138.73M |
| Financing cash flow | -$491.44M | -$492.53M | $1.80B | $1.24B | -$401.87M | -$335.22M | -$339.64M | $951.22M | -$37.30M |
Quarterly
| Line item | Aug 2026 | May 2026 | Feb 2026 | Nov 2025 | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 | Feb 2024 | Nov 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $268.21M | $257.89M | -$83.22M | $344.22M | $224.80M | $236.54M | $1.41M | $284.40M | $191.62M | $238.34M | -$46.87M | $229.26M |
| Capital expenditures | $46.98M | $48.17M | $53.90M | $63.03M | $65.05M | $55.79M | $50.62M | $59.87M | $62.75M | $60.09M | $56.06M | $64.81M |
| Free cash flow | $221.23M | $209.72M | -$137.12M | $281.19M | $159.75M | $180.74M | -$49.21M | $224.53M | $128.88M | $178.25M | -$102.93M | $164.45M |
Frequently Asked Questions About CNXC
What is Concentrix's annual revenue?
Concentrix reported revenue of $9.83B for the fiscal year ended Nov 30, 2025.
How fast is Concentrix's revenue growing?
Revenue was up 2.2% for the fiscal year ended Nov 30, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 15.8%.
Is Concentrix profitable?
No. Concentrix reported net income of -$1.28B for the fiscal year ended Nov 30, 2025, with a net margin of -13.0%.
How much free cash flow does CNXC generate?
For the fiscal year ended Nov 30, 2025, operating cash flow of $806.97M minus capital expenditures of $234.50M produced free cash flow of $572.47M.
How much debt does Concentrix have?
The balance sheet dated Nov 30, 2025 reported long-term debt of $4.57B, short-term debt of $65.63M and cash and equivalents of $327.35M.
CNXC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts